GSK  LON GSK  stock fell 0.7  after the British drugmaker said it had raised just under £1 billion from a discounted stake sale in Haleon, cutting its shareholding to 4.2  in the world's largest standalone consumer healthcare firm.
GSK's stock price dropped 0.7% after it sold a portion of its stake in Haleon, reducing its ownership to 4.2% and raising £1 billion.